The Philosophy of GBBT

Contribute to the health of the society.

We believe in the power of technology, science, and human empathy to make the journey simplier.

 Let us help you continue to find joy in life.

Founded in Hong Kong in 2021, Greater Bay Biotechnology has leading R&D capabilities in the field of functional hyaluronic acid and microneedling transdermal drug delivery. 

We are committed to developing safer, high-quality products with innovative technology to create healthy 

and beautiful lives for our customers.

在知名学术期刊发表 >200篇论文

研发团队100%硕博士

>40年工业与生产经验

Innovative technology company, 

continuing the spirit of science

Constantly improving, 

in order to achieve perfection

Our particular focus is innovative delivery of biological drug or biologics, which includes peptide/protein, nucleic acid, mRNA, cell, cell derived vesicles, many of which are commonly used in the treatment of major diseases (e.g., metabolic disease, cancer) and also in beauty and cosmetics.

Greater Bay Biotechnology of Research has won many awards in science and technology innovation competitions both locally and internationally.

Our expected test results were validated

Greater Bay Biotechnology (GBBT) is a business supported by City University of Hong Kong (CityU) HK Tech 300 program, HKSTP Ideation program and HKSAR Government Innovation and

Technology Fund.

The CMN research was published at Nature Biomedical Engineering in May 2021 and CityU has applied for a US patent on CMN and GBBT has licensing arrangement with CityU.

>40年工商管理与资本市场经验

Honors & Awards

2021.08: Greater Bay Biotechnology's "New Generation of Microneedle Medical Devices for Delivery of Cells and Biological Products" won the second prize.

2021.07: 2nd Runner Up @ “Maker in China” SME IEGC HK, 4th in Overseas Contest.

2021.06：Greater Bay Biotechnology (GBBT) is a business supported by City University of Hong Kong (CityU) HK Tech 300 program.

2021.05：The CMN research was published at Nature Biomedical Engineering in May 2021.